Importantly, LIF e exerts a complex influence on cancer development, exhibiting both tumor‐suppressive effects (mainly in leukemia) and tumor‐promoting effects (in many solid tumors, including pancreatic, breast, and colorectal cancers) [11, 12]. The gene discussed is LIF; the disease is cancer.